Imricor Medical Systems Inc (IMR) - Total Assets
Based on the latest financial reports, Imricor Medical Systems Inc (IMR) holds total assets worth AU$45.79 Million AUD (≈ $32.40 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Imricor Medical Systems Inc - Total Assets Trend (2016–2025)
This chart illustrates how Imricor Medical Systems Inc's total assets have evolved over time, based on quarterly financial data. Also see IMR market cap for the company's overall valuation and market capitalisation.
Imricor Medical Systems Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Imricor Medical Systems Inc's total assets of AU$45.79 Million consist of 93.8% current assets and 6.2% non-current assets. Review IMR total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 42.6% |
| Accounts Receivable | AU$241.03K | 0.5% |
| Inventory | AU$1.10 Million | 2.4% |
| Property, Plant & Equipment | AU$2.14 Million | 4.7% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Imricor Medical Systems Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Imricor Medical Systems Inc stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Imricor Medical Systems Inc's current assets represent 93.8% of total assets in 2025, an increase from 90.2% in 2016.
- Cash Position: Cash and equivalents constituted 42.6% of total assets in 2025, down from 83.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 4.7% of total assets.
Imricor Medical Systems Inc Competitors by Total Assets
Key competitors of Imricor Medical Systems Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Stratec SE
XETRA:SBS
|
Germany | €408.98 Million |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
DRTECH Corporation
KQ:214680
|
Korea | ₩235.84 Billion |
|
Novacyt
PA:ALNOV
|
France | €40.28 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
Imricor Medical Systems Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.47 | 7.79 | 12.58 |
| Quick Ratio | 2.41 | 7.15 | 11.24 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | AU$25.56 Million | AU$15.99 Million | AU$34.57 Million |
Imricor Medical Systems Inc - Advanced Valuation Insights
This section examines the relationship between Imricor Medical Systems Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 45.05 |
| Latest Market Cap to Assets Ratio | 10.25 |
| Asset Growth Rate (YoY) | 111.7% |
| Total Assets | AU$45.79 Million |
| Market Capitalization | $469.33 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Imricor Medical Systems Inc's assets at a significant premium (10.25x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Imricor Medical Systems Inc's assets grew by 111.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Imricor Medical Systems Inc (2016–2025)
The table below shows the annual total assets of Imricor Medical Systems Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | AU$45.79 Million ≈ $32.40 Million |
+111.75% |
| 2024-12-31 | AU$21.62 Million ≈ $15.30 Million |
+160.27% |
| 2023-12-31 | AU$8.31 Million ≈ $5.88 Million |
-39.36% |
| 2022-12-31 | AU$13.70 Million ≈ $9.69 Million |
-49.00% |
| 2021-12-31 | AU$26.86 Million ≈ $19.01 Million |
-19.97% |
| 2020-12-31 | AU$33.57 Million ≈ $23.75 Million |
+219.05% |
| 2019-12-31 | AU$10.52 Million ≈ $7.44 Million |
-34.47% |
| 2018-12-31 | AU$16.06 Million ≈ $11.36 Million |
+435.48% |
| 2017-12-31 | AU$3.00 Million ≈ $2.12 Million |
-13.46% |
| 2016-12-31 | AU$3.47 Million ≈ $2.45 Million |
-- |
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatib… Read more